Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: Apoptosis induction by TRAIL

Molecular and Cellular Proteomics

Volumn 11, Issue 3, 2012, Pages

  Szegezdi, Eva ^a   Van Der Sloot, Almer M ^b   Mahalingam, Devalingam ^a   O'Leary, Lynda ^a   Cool, Robbert H ^c   Muñoz, Inés G ^d   Montoya, Guillermo ^d   Quax, Wim J ^c   De Jong, Steven ^e   Samali, Afshin ^a   Serrano, Luis ^b,f  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d Structural Biology and Biocomputing Programme   (Spain)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; MEMBRANE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; COMPLEX FORMATION; COMPUTER MODEL; CONTROLLED STUDY; HUMAN; KINETICS; LIGAND BINDING; METABOLISM; OLIGOMERIZATION; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; THEORETICAL MODEL; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL PROLIFERATION; HUMANS; KINETICS; METABOLISM; MODELS, THEORETICAL; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84857959276     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.013730     Document Type: Article

References (64)

1. Bodmer, J. L., Schneider, P., and Tschopp, J. (2002) The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26 (Pubitemid 34131621)
2. Eswarakumar, V. P., Lax, I., and Schlessinger, J. (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149 (Pubitemid 40616112)
3. Ferguson, K. M. (2008) Structure-based view of epidermal growth factor receptor regulation. Annu. Rev. Biophys. 37, 353-373
4. Shibuya, M., and Claesson-Welsh, L. (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp. Cell Res. 312, 549-560 (Pubitemid 43290332)
5. Buchler, N. E., and Louis, M. (2008) Molecular titration and ultrasensitivity in regulatory networks. J. Mol. Biol. 384, 1106-1119
6. Kiel, C., and Serrano, L. (2009) Cell type-specific importance of Ras-c-Raf complex association rate constants for MAPK signaling. Sci. Signal. 2, ra38
7. Reis, C. R., van der Sloot, A. M., Natoni, A., Szegezdi, E., Setroikromo, R., Meijer, M., Sjollema, K., Stricher, F., Cool, R. H., Samali, A., Serrano, L., and Quax, W. J. (2010) Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants. Cell Death Dis. 1, e83
8. Ashkenazi, A., and Dixit, V. M. (1998) Death receptors: Signaling and modulation. Science 281, 1305-1308 (Pubitemid 28406815)
9. Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., DeForge, L., Koumenis, I. L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z., and Schwall, R. H. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155-162
10. Falschlehner, C., Emmerich, C. H., Gerlach, B., and Walczak, H. (2007) TRAIL signalling: Decisions between life and death. Int. J. Biochem. Cell Biol. 39, 1462-1475 (Pubitemid 47031030)
11. Stennicke, H. R., Deveraux, Q. L., Humke, E. W., Reed, J. C., Dixit, V. M., and Salvesen, G. S. (1999) Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 274, 8359-8362 (Pubitemid 29164620)
12. Li, H., Zhu, H., Xu, C. J., and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501 (Pubitemid 28391865)
13. Algeciras-Schimnich, A., Shen, L., Barnhart, B. C., Murmann, A. E., Burkhardt, J. K., and Peter, M. E. (2002) Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22, 207-220 (Pubitemid 33144269)
14. Albeck, J. G., Burke, J. M., Spencer, S. L., Lauffenburger, D. A., and Sorger, P. K. (2008) Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biol. 6, 2831-2852
15. Thorpe, J. A., Christian, P. A., and Schwarze, S. R. (2008) Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis. Prostate 68, 200-209 (Pubitemid 351186232)
16. Albeck, J. G., Burke, J. M., Aldridge, B. B., Zhang, M., Lauffenburger, D. A., and Sorger, P. K. (2008) Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol. Cell 30, 11-25 (Pubitemid 351470145)
17. McDonald, E. R., 3rd, and El-Deiry, W. S. (2004) Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc. Natl. Acad. Sci. U.S.A. 101, 6170-6175
18. LeBlanc, H. N., and Ashkenazi, A. (2003) Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10, 66-75 (Pubitemid 36511833)
19. Marsters, S. A., Sheridan, J. P., Pitti, R. M., Huang, A., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A. D., Godowski, P., and Ashkenazi, A. (1997) A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7, 1003-1006 (Pubitemid 28017080)
20. Mérino, D., Lalaoui, N., Morizot, A., Schneider, P., Solary, E., and Micheau, O. (2006) Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol. Cell. Biol. 26, 7046-7055 (Pubitemid 44477684)
21. Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R., and Dixit, V. M. (1997) An antagonist decoy receptor and a death domain-Containing receptor for TRAIL. Science 277, 815-818 (Pubitemid 27366732)
22. Chan, F. K. (2007) Three is better than one: Pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine 37, 101-107
23. Chan, F. K., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., and Lenardo, M. J. (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351-2354 (Pubitemid 30448156)
24. Clancy, L., Mruk, K., Archer, K., Woelfel, M., Mongkolsapaya, J., Screaton, G., Lenardo, M. J., and Chan, F. K. (2005) Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 102, 18099-18104 (Pubitemid 41798508)
25. Lee, H. W., Lee, S. H., Lee, H. W., Ryu, Y. W., Kwon, M. H., and Kim, Y. S. (2005) Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors. Biochem. Biophys. Res. Commun. 330, 1205-1212
26. Truneh, A., Sharma, S., Silverman, C., Khandekar, S., Reddy, M. P., Deen, K. C., McLaughlin, M. M., Srinivasula, S. M., Livi, G. P., Marshall, L. A., Alnemri, E. S., Williams, W. V., and Doyle, M. L. (2000) Temperature-sensitive differential affinity of TRAIL for its receptors: DR5 is the highest affinity receptor. J. Biol. Chem. 275, 23319-23325 (Pubitemid 30646233)
27. Ander, M., Beltrao, P., Di Ventura, B., Ferkinghoff-Borg, J., Foglierini, M., Kaplan, A., Lemerle, C., Tomas-Oliveira, I., and Serrano, L. (2004) Smart-Cell, a framework to simulate cellular processes that combines stochastic approximation with diffusion and localisation: Analysis of simple networks. Syst. Biol. 1, 129-138
28. van der Sloot, A. M., Tur, V., Szegezdi, E., Mullally, M. M., Cool, R. H., Samali, A., Serrano, L., and Quax, W. J. (2006) Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor. Proc. Natl. Acad. Sci. U.S.A. 103, 8634-8639 (Pubitemid 43878072)
29. Duiker, E. W., de Vries, E. G., Mahalingam, D., Meersma, G. J., Boersmavan Ek, W., Hollema, H., Lub-de Hooge, M. N., van Dam, G. M., Cool, R. H., Quax, W. J., Samali, A., van der Zee, A. G., and de Jong, S. (2009) Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model. Clin. Cancer Res. 15, 2048-2057
30. van der Sloot, A. M., Mullally, M. M., Fernandez-Ballester, G., Serrano, L., and Quax, W. J. (2004) Stabilization of TRAIL, an all-β-sheet multimeric protein, using computational redesign. Protein Eng. Des. Sel. 17, 673-680 (Pubitemid 40601887)
31. Duiker, E. W., Mom, C. H., de Jong, S., Willemse, P. H., Gietema, J. A., van der Zee, A. G., and de Vries, E. G. (2006) The clinical trail of TRAIL. Eur. J. Cancer 42, 2233-2240 (Pubitemid 44307615)
32. Szegezdi, E., Cahill, S., Meyer, M., O'Dwyer, M., and Samali, A. (2006) TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt. Br. J. Cancer 94, 398-406 (Pubitemid 43237564)
33. Holohan, C., Szegezdi, E., Ritter, T., O'Brien, T., and Samali, A. (2008) Cytokine-induced β-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. J. Cell Mol. Med. 12, 591-606 (Pubitemid 351555138)
34. Szegezdi, E., Herbert, K. R., Kavanagh, E. T., Samali, A., and Gorman, A. M. (2008) Nerve growth factor blocks thapsigargin-induced apoptosis at the level of the mitochondrion via regulation of Bim. J. Cell Mol. Med. 12, 2482-2496
35. Tamura, A., and Privalov, P. L. (1997) The entropy cost of protein association. J. Mol. Biol. 273, 1048-1060 (Pubitemid 27501159)
36. Ben-Tal, N., Honig, B., Bagdassarian, C. K., and Ben-Shaul, A. (2000) Association entropy in adsorption processes. Biophys. J. 79, 1180-1187
37. Wang, L., Yang, J. K., Kabaleeswaran, V., Rice, A. J., Cruz, A. C., Park, A. Y., Yin, Q., Damko, E., Jang, S. B., Raunser, S., Robinson, C. V., Siegel, R. M., Walz, T., and Wu, H. (2010) The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat. Struct. Mol. Biol. 17, 1324-1329
38. Klein, J. S., Gnanapragasam, P. N., Galimidi, R. P., Foglesong, C. P., West, A. P., Jr., and Bjorkman, P. J. (2009) Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10. Proc. Natl. Acad. Sci. U.S.A. 106, 7385-7390
39. Lortat-Jacob, H., Chouin, E., Cusack, S., and van Raaij, M. J. (2001) Kinetic analysis of adenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions. J. Biol. Chem. 276, 9009-9015
40. Kim, S. H., Kim, K., Kwagh, J. G., Dicker, D. T., Herlyn, M., Rustgi, A. K., Chen, Y., and El-Deiry, W. S. (2004) Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human esophageal epithelial cells. J. Biol. Chem. 279, 40044-40052 (Pubitemid 39258279)
41. Elf, J., and Ehrenberg, M. (2004) Spontaneous separation of bi-stable biochemical systems into spatial domains of opposite phases. Syst. Biol. 1, 230-236
42. Elf, J., Doncic, A., and Ehrenberg, M. (2003) Mesoscopic reaction-diffusion in intracellular signaling. In Fluctuations and Noise in Biological, Biophysical, and Biomedical Systems (Bezrukov, S. M., Frauenfelder, H., and Moss, F., eds), pp. 114-124, Bellingham WA98227-0010 USA; volume 5110
43. Dublanche, Y., Michalodimitrakis, K., Kummerer, N., Foglierini, M., and Serrano, L. (2006) Noise in transcription negative feedback loops: Simulation and experimental analysis. Mol. Syst. Biol. 2, 41
44. Boschert, V., Krippner-Heidenreich, A., Branschädel, M., Tepperink, J., Aird, A., and Scheurich, P. (2010) Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2. Cell Signal. 22, 1088-1096
45. Naismith, J. H., Devine, T. Q., Brandhuber, B. J., and Sprang, S. R. (1995) Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J. Biol. Chem. 270, 13303-13307
46. Tartaglia, L. A., Pennica, D., and Goeddel, D. V. (1993) Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268, 18542-18548 (Pubitemid 23273787)
47. Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., and Ashkenazi, A. (2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611-620
48. Mongkolsapaya, J., Grimes, J. M., Chen, N., Xu, X. N., Stuart, D. I., Jones, E. Y., and Screaton, G. R. (1999) Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat. Struct. Biol. 6, 1048-1053 (Pubitemid 29519600)
49. Hymowitz, S. G., Christinger, H. W., Fuh, G., Ultsch, M., O'Connell, M., Kelley, R. F., Ashkenazi, A., and de Vos, A. M. (1999) Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell 4, 563-571 (Pubitemid 29531136)
50. Reis, C. R., van Assen, A. H., Quax, W. J., and Cool, R. H. (2012) Unraveling the binding mechanism of trivalent tumor necrosis factor ligands and their receptors. Mol. Cell. Proteomics 10, M110.002808
51. Mahalingam, D., Szegezdi, E., Keane, M., de Jong, S., and Samali, A. (2009) TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat. Rev. 35, 280-288
52. Sheikh, M. S., Huang, Y., Fernandez-Salas, E. A., El-Deiry, W. S., Friess, H., Amundson, S., Yin, J., Meltzer, S. J., Holbrook, N. J., and Fornace, A. J., Jr. (1999) The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract. Oncogene 18, 4153-4159 (Pubitemid 29363923)
53. Chou, T. C., and Talalay, P. (1984) Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27-55
54. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462
55. Zhang, X. D., Franco, A. V., Nguyen, T., Gray, C. P., and Hersey, P. (2000) Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells. J. Immunol. 164, 3961-3970 (Pubitemid 30215048)
56. Kelley, S. K., Harris, L. A., Xie, D., Deforge, L., Totpal, K., Bussiere, J., and Fox, J. A. (2001) Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: Characterization of in vivo efficacy, pharmacokinetics, and safety. J. Pharmacol. Exp. Ther. 299, 31-38 (Pubitemid 32905115)
57. Kim, S., Choi, K., Kwon, D., Benveniste, E. N., and Choi, C. (2004) Ubiquitin-proteasome pathway as a primary defender against TRAIL-mediated cell death. Cell. Mol. Life Sci. 61, 1075-1081 (Pubitemid 38626510)
58. Dijk, M. v., Murphy, E., Morrell, R., Knapper, S., O'Dwyer, M., Samali, A., and Szegezdi, E. (2011) The proteasome inhibitor bortezomib sensitizes AML with myelomonocytic differentiation to TRAIL mediated apoptosis. Cancers 3, 1329-1350
59. Rehm, M., Dussmann, H., Janicke, R. U., Tavare, J. M., Kogel, D., and Prehn, J. H. (2002) Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process: Role of caspase-3. J. Biol. Chem. 277, 24506-24514 (Pubitemid 34951976)
60. Hellwig, C. T., Kohler, B. F., Lehtivarjo, A. K., Dussmann, H., Courtney, M. J., Prehn, J. H., and Rehm, M. (2008) Real time analysis of tumor necrosis factor-related apoptosis-inducing ligand/cycloheximide-induced caspase activities during apoptosis initiation. J. Biol. Chem. 283, 21676-21685
61. Spencer, S. L., Gaudet, S., Albeck, J. G., Burke, J. M., and Sorger, P. K. (2009) Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459, 428-432
62. Oldenhuis, C. N., Stegehuis, J. H., Walenkamp, A. M., de Jong, S., and de Vries, E. G. (2008) Targeting TRAIL death receptors. Curr. Opin. Pharmacol. 8, 433-439
63. Vigneswaran, N., Baucum, D. C., Wu, J., Lou, Y., Bouquot, J., Muller, S., and Zacharias, W. (2007) Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression. BMC Cancer 7, 108
64. Zhang, X. D., Franco, A., Myers, K., Gray, C., Nguyen, T., and Hersey, P. (1999) Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res. 59, 2747-2753 (Pubitemid 29269125)